Drug Shortage Report for MAR-DILTIAZEM CD
Report ID | 124005 |
Drug Identification Number | 02484099 |
Brand name | MAR-DILTIAZEM CD |
Common or Proper name | DILTIAZEM CD |
Company Name | MARCAN PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | DILTIAZEM HYDROCHLORIDE |
Strength(s) | 300MG |
Dosage form(s) | CAPSULE (CONTROLLED-DELIVERY) |
Route of administration | ORAL |
Packaging size | 100 Tablet |
ATC code | C08DB |
ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2020-09-08 |
Actual start date | 2020-09-08 |
Estimated end date | 2021-11-15 |
Actual end date | 2022-03-10 |
Shortage status | Resolved |
Updated date | 2022-07-20 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-09-09 | English | Compare |
v2 | 2020-09-09 | French | Compare |
v3 | 2020-11-20 | English | Compare |
v4 | 2020-11-20 | French | Compare |
v5 | 2021-03-15 | English | Compare |
v6 | 2021-03-15 | French | Compare |
v7 | 2021-08-05 | English | Compare |
v8 | 2021-08-05 | French | Compare |
v9 | 2022-07-20 | English | Compare |
v10 | 2022-07-20 | French | Compare |
Showing 1 to 10 of 10